drugset / Trial / NCT06398808
A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of ZYIL1 oral capsule twice a day for 12 weeks for treatment of mild to moderate active ulcerative colitis resistant or intolerant to oral aminosalicylates.
Timeline
- Start
- 2024-04-08
- Primary completion
- 2024-11-22
- Completion
- 2024-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Usnoflast | Small molecule | 25 mg | Oral |
| Subject | Usnoflast | Small molecule | 50 mg | Oral |